共 36 条
[1]
Wegman P(2005)Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients Breast Cancer Res 7 R284-R290
[2]
Vainikka L(2004)Pharmacogenomic determinants of outcome with tamoxifen therapy: findings from the randomized North Central Cancer Treatment Group adjuvant breast cancer trial 89-30-52 Breast Cancer Res Treat 88 S35-1764
[3]
Stal O(2003)Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine J Natl Cancer Inst 95 1758-39
[4]
Nordenskjold B(2005)CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment J Natl Cancer Inst 97 30-undefined
[5]
Skoog L(undefined)undefined undefined undefined undefined-undefined
[6]
Rutqvist LE(undefined)undefined undefined undefined undefined-undefined
[7]
Wingreb S(undefined)undefined undefined undefined undefined-undefined
[8]
Goetz MP(undefined)undefined undefined undefined undefined-undefined
[9]
Rae JM(undefined)undefined undefined undefined undefined-undefined
[10]
Suman VJ(undefined)undefined undefined undefined undefined-undefined